As the global economy mends, the 2021 growth of Hospital-Acquired Infection Control will have significant change from previous year. According to our researcher latest study, the global Hospital-Acquired Infection Control market size is USD million in 2022 from USD 5578.1 million in 2021, with a change of % between 2021 and 2022. The global Hospital-Acquired Infection Control market size will reach USD 6859.5 million in 2028, growing at a CAGR of 3.0% over the analysis period.

The United States Hospital-Acquired Infection Control market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Hospital-Acquired Infection Control market, reaching US$ million by the year 2028. As for the Europe Hospital-Acquired Infection Control landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Hospital-Acquired Infection Control players cover GSK, Merck, Pfizer, and 3M, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Hospital-Acquired Infection Control market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Catheter-associated Urinary Tract Infections (CAUTIs)

Surgical Site Infections (SSIs)

Central Line-associated Bloodstream Infections (CLABSIs)

Respiratory Infections

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospitals and ICUs

Outpatient Care Centers

Long-term Care Facilities (LTCFs)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

GSK

Merck

Pfizer

3M

Abbott

BD

Cepheid

Getinge Group